GEN1047 for Solid Tumors - First in Human (FIH) Trial
Genmab
Genmab
Novartis
Conjupro Biotherapeutics, Inc.
Criterium, Inc.
Sotio Biotech Inc.
Biocon Limited
Allarity Therapeutics
Genmab
Sanofi
Takeda
Ocellaris Pharma, Inc.
Palleos Healthcare GmbH
Seagen Inc.
Fusion Pharmaceuticals Inc.
PharmAbcine
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Regeneron Pharmaceuticals
Novartis
Sanofi
Transgene
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc.
Novartis
Pfizer
Taiho Oncology, Inc.
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Nuvation Bio Inc.
Gilead Sciences
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
Taiho Oncology, Inc.
Novartis
Zenith Epigenetics
Sanofi
NiKang Therapeutics, Inc.
Palleos Healthcare GmbH
Sanofi
Sanofi
Bolt Biotherapeutics, Inc.
Sanofi
Sanofi
CytoDyn, Inc.
SBI ALApharma Canada, Inc.
Alaunos Therapeutics
Alaunos Therapeutics
Eli Lilly and Company
Hoffmann-La Roche
MacroGenics
Ourotech, Inc.